Rev Med Virol. 2015 May;25(3):187-201. doi: 10.1002/rmv.1836. Epub 2015 Apr 1. Research Support, Non-U.S. Gov't; Review
Your new post is loading...
Your new post is loading...
Gilbert C FAURE's curator insight,
January 7, 2016 9:19 AM
Mast cells have mainly been studied in the setting of allergic disease, but the importance of mast cells for host defence against several pathogens has now been well established. The location of mast cells, which are found closely associated with blood vessels, allows them to have a crucial sentinel role in host defence. The mast cell has a unique 'armamentarium' of receptor systems and mediators for responding to pathogen-associated signals. Studies of this intriguing immune-effector cell provide important insights into the complex mechanisms by which appropriate innate and acquired immune responses are initiated. a review from 2004 focusing on immunological role of mast cells
Krishan Maggon 's curator insight,
December 28, 2015 8:15 AM
Current Opinion in Immunology Volume 38, February 2016, Pages 45–51 Innate immunity |
Krishan Maggon 's curator insight,
December 28, 2015 3:06 AM
Current Opinion in Immunology Volume 39, April 2016, Pages 1–6 Lymphocyte development and activation * Tumour immunology
Krishan Maggon 's curator insight,
December 28, 2015 3:09 AM
Current Opinion in Immunology Volume 39, April 2016, Pages 1–6 Lymphocyte development and activation * Tumour immunology |
Type I-interferon (IFN-I) induction pathway is one of the most commonly stimulated signaling pathways in response to viral infection. During viral infection this pathway is stimulated by various pattern-recognition receptors, which recognize different pathogen-associated molecular patterns. The pathways stimulated by different pattern-recognition receptors merge into common transcription factors IRF3 and IRF7, lead to the production of IFN-I. The secreted IFN-I stimulates JAK-STAT pathway leading to induction of interferon-stimulated genes (ISGs). The ISGs along with IFN-I create antiviral state to eliminate the virus from host. HHV infection enhances IFN-I-mediated innate antiviral response during both de novo infection and lytic reactivation from latency. However, HHV developed various molecular strategies to evade the sudden upsurge of the IFN-I and IFN-I-mediated antiviral response to establish a successful infection. Here, we focus on IFN-I induction and signaling pathways induced by three representative HHVs from each sub-family of HHV and strategies acquired by these HHVs to subvert the induction of IFN-I and ISGs to evade the host innate immunity. These fundamental understanding provides the clue for viral targets for pharmacological manipulation to develop potential therapeutics for broad subtypes of HHVs.